Literature DB >> 10887482

Genetic manipulation of mammary epithelium by transplantation.

P A Edwards1, C L Abram, J M Bradbury.   

Abstract

Genes can be introduced into mammary epithelium in vivo by the 'tissue reconstitution' method. Primary cultures of mammary epithelial cells are prepared, a gene introduced using retrovirus vectors, and the cells transplanted into a mammary fat pad from which the normal epithelium has been removed. The cells reform an epithelium in which some cells express the introduced gene. The technique is reviewed and compared with the mammary-specific expression of genes in transgenic mice. To model the development of neoplasia, particularly the preneoplastic changes caused by a single oncogene alone, several oncogenes have been expressed this way--myc, Ha-ras, erbB, erbB2, Wnt-1, and hst/FGF-4. Each caused a different alteration to the growth pattern of the epithelium, such as altered branching, premature alveolus development, distorted duct structure, or altered hormone sensitivity. Insights into normal development have also been obtained by inappropriate expression of genes such as Wnt-4.

Entities:  

Mesh:

Year:  1996        PMID: 10887482     DOI: 10.1007/BF02096304

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  49 in total

Review 1.  Retroviral vectors.

Authors:  A D Miller
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice.

Authors:  G Friedrich; P Soriano
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

3.  Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

Authors:  T C Thompson; J Southgate; G Kitchener; H Land
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

4.  Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development.

Authors:  S Coleman-Krnacik; J M Rosen
Journal:  Mol Endocrinol       Date:  1994-02

5.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

6.  Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.

Authors:  T P Lin; R C Guzman; R C Osborn; G Thordarson; S Nandi
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

7.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos.

Authors:  I R Ghattas; J R Sanes; J E Majors
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

8.  Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells.

Authors:  G H Smith; D Gallahan; J A Zwiebel; S M Freeman; R H Bassin; R Callahan
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.

Authors:  C Jhappan; D Gallahan; C Stahle; E Chu; G H Smith; G Merlino; R Callahan
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

10.  TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization.

Authors:  C W Daniel; G B Silberstein; K Van Horn; P Strickland; S Robinson
Journal:  Dev Biol       Date:  1989-09       Impact factor: 3.582

View more
  13 in total

Review 1.  The mammary fat pad.

Authors:  M C Neville; D Medina; J Monks; R C Hovey
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 2.  Conditional control of gene expression in the mammary gland.

Authors:  P A Furth
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 3.  The mammary gland: a unique organ for the study of development and tumorigenesis.

Authors:  D Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

4.  The Journal of Mammary Gland Biology and Neoplasia into the future - the potential of plasticity and pluripotency.

Authors:  Russell C Hovey; David Salomon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-06       Impact factor: 2.673

5.  Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer.

Authors:  Bryan E Welm; Gerrit J P Dijkgraaf; Anita S Bledau; Alana L Welm; Zena Werb
Journal:  Cell Stem Cell       Date:  2008-01-10       Impact factor: 24.633

6.  Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.

Authors:  R H Lachmann; S Efstathiou
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 7.  On the shoulders of giants: a historical perspective of unique experimental methods in mammary gland research.

Authors:  Brittni A Smith; Alana L Welm; Bryan E Welm
Journal:  Semin Cell Dev Biol       Date:  2012-03-09       Impact factor: 7.727

8.  Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.

Authors:  B R Davies; A M Platt-Higgins; G Schmidt; P S Rudland
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

9.  Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.

Authors:  Rachel L Dusek; Jamie L Bascom; Hannes Vogel; Sylvain Baron; Alexander D Borowsky; Mina J Bissell; Laura D Attardi
Journal:  Breast Cancer Res       Date:  2012-04-20       Impact factor: 6.466

10.  Nucleostemin maintains self-renewal of embryonic stem cells and promotes reprogramming of somatic cells to pluripotency.

Authors:  Jian Qu; J Michael Bishop
Journal:  J Cell Biol       Date:  2012-06-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.